In this link that happened to you, a study on the antidiabetic Vildagliptin (DPP-4) is published, it is marketed under the names of Galvus and Eukreas.

<!.san.gva.es/cas/prof/dgf/pharm ...

Not everything that the Ministry of Health does is wrong: Mrgreen: